Literature DB >> 19337743

[Vasculitis: histopathology and differential diagnosis].

K Holl-Ulrich1, F Noack, A C Feller.   

Abstract

A histopathologically confirmed biopsy is the gold standard for the diagnosis of vasculitis. Possible etiologies include primary systemic vasculitis, secondary vasculitis or isolated single organ vasculitis, although on histopathological grounds alone a clear differentiation is frequently not possible. The key criteria of morphological vasculitis work-up include vessel size, type of inflammation (granulomatous, necrotizing and/or leukocytoclastic) as well as the presence or absence of immune complexes and extravascular inflammatory changes. Together with the typical organ involvement and serological data, these criteria constitute the basis of vasculitis classification. Differential diagnostic overlaps and possible discrimination methods are presented. In the same way that the clinical approach of vasculitis patients is an interdisciplinary one, histopathology can only provide a definite diagnosis in combination with clinical and serological data. A conclusive morphological diagnosis depends on the right time of biopsy and the selection of appropriate biopsy material.

Entities:  

Mesh:

Year:  2009        PMID: 19337743     DOI: 10.1007/s00393-008-0402-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  26 in total

Review 1.  [Cryoglobulinemic vasculitis].

Authors:  A Gause; P Lamprecht
Journal:  Internist (Berl)       Date:  2003-02       Impact factor: 0.743

Review 2.  Medium- and large-vessel vasculitis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

Review 3.  Single-organ vasculitis.

Authors:  José Hernández-Rodríguez; Eamonn S Molloy; Gary S Hoffman
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

Review 4.  Disease patterns in vasculitis-still a mystery.

Authors:  Gary S Hoffman
Journal:  Bull NYU Hosp Jt Dis       Date:  2008

5.  Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.

Authors:  Loïc Guillevin; Alfred Mahr; Patrice Callard; Pascal Godmer; Christian Pagnoux; Emmanuelle Leray; Pascal Cohen
Journal:  Medicine (Baltimore)       Date:  2005-09       Impact factor: 1.889

6.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients.

Authors:  L Guillevin; B Durand-Gasselin; R Cevallos; M Gayraud; F Lhote; P Callard; J Amouroux; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  1999-03

Review 7.  Vasculitides secondary to infections.

Authors:  C Pagnoux; P Cohen; L Guillevin
Journal:  Clin Exp Rheumatol       Date:  2006 Mar-Apr       Impact factor: 4.473

8.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

Review 9.  [Giant cell arteritis (temporal arteritis). Pathophysiology, immunology].

Authors:  A D Wagner
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

Review 10.  [Histology of cutaneous vasculitides].

Authors:  A Stein; I Hackert; M Meurer
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

View more
  3 in total

1.  [Polyarteritis nodosa: differential diagnostics and therapy].

Authors:  J H Schirmer; K Holl-Ulrich; F Moosig
Journal:  Z Rheumatol       Date:  2014-12       Impact factor: 1.372

Review 2.  Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa.

Authors:  Alojzija Hočevar; Matija Tomšič; Katja Perdan Pirkmajer
Journal:  Curr Rheumatol Rep       Date:  2021-02-10       Impact factor: 4.592

Review 3.  [Is bioptic assurance reasonable in patients with Sjögren's syndrome? From focus score to diagnosing vasculitides].

Authors:  V Krenn; M Jakobs; J Kriegsmann; M G Krukemeyer; A Rieger
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.